• Home
  • Search Results

Search Results

Young Adult (18-34)
2364 studies match your search
Not currently enrolling

Wellbeing of Military Soldiers Study

In this study, we want to learn how underrepresented soldiers stay resilient, fit, and healthy.

Age & Gender
  • 18 years ~ 65 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Mental and Emotional Health
  • Opinions and Perceptions
  • and 4 more
Not currently enrolling

Type I Diabetic Insulin Study

The purpose of this study is to find out whether the addition of HDV to Humalog® will improve diabetes control by reducing high blood sugar after meals and/or reducing the risk of low blood sugar (hypoglycemia) during insulin treatment. The safety and tolerability of Humalog® with or without added HDV will also be evaluated. The study drugs will be administered by subcutaneous (under the skin) injection.

Age & Gender
  • 18 years ~ 79 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Kidneys and Liver
Not currently enrolling

Study on Hispanic/Latino Identity

In this study, I want to learn how people who identify as Latino, Hispanic, and/or from Latin America make sense of and understand their identity.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

UNC Public Speaking Study

The purpose of this research study is to better understand how day-to-day differences in people's public speaking anxiety relate to how well they respond to therapy for public speaking anxiety.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Mental and Emotional Health
  • UNC or UNC Health employees
  • and 3 more
Open

ARGX-113-2308

Efgartigimod has been approved by the U.S. FDA (Food and Drug Administration) as a treatment for adult patients with gMG in whom AChR-Ab's are present. However, it was not approved it for the form of gMG that is AChR Ab seronegative (antibodies not present). and therefore this study is now testing how efragtigimod works in patients without any antibodies,

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
Not currently enrolling

Usability Study of an Explainable AI-driven Risk Assessment Tool for the Prediction of Postpartum Depression

The focus of the research is on the challenges associated with achieving explainability in analytics and AI powered approaches applied in risk predictions in maternal health. As part of this research, we aim to conduct a usability study of an AI-driven postpartum depression risk assessment tool engaging healthcare providers - including doctors, nurses, and midwives - as participants. The usability study will assess healthcare provider's interactions and engagement with the web-based tool, measured by the System Explainability Scale (SES) Score, which quantifies its overarching Explainability, considering the dimensions of understandability, trust, and usability.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Mental and Emotional Health
  • Pregnancy
  • Women's Health
  • and 4 more
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

AI-based Communication Study

In this study, we want to see if AI chatbots give quality health advice to cancer survivors. We want to see if these responses can help providers and doctors respond well to patients' questions and needs.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast, Prostate)
Visit Location
100% Remote (online, phone, text)
Open

Anifrolumab in HS

Do you have Hidradenitis Suppurativa (HS)? You may be eligible to participate in a research study assessing the effect of an investigational product in HS and its impact on quality of life. If eligible, and you decide to participate, you will receive the study drug study related medical evaluation and compensation for completed visits.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Minority Health
  • Rare Diseases
  • Skin, Hair, and Nails
Open

Adults with Blood Cancer

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AK117 to patients with Leukemia

Age & Gender
  • 18 years ~ 99 years
  • Male, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Not currently enrolling

Knowledge of the Treatment of Female Reproductive Issues via Diet/Nutrition

This project seeks to analyze the information given to women by doctors about what foods and nutritional supplements to take to help with issues related to the gut microbiota and nutrition, including acne, PCOS, irregular menstrual cycles, and osteoporosis. Through oral interviews of both doctors and biological women aged 18+, I will study nutritional advice given, frequency of the advice, whether advice is given to address reproductive health issues or to address perceived issues of weight, and where women are getting their nutritional advice if not from a doctor.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Alternative or Complementary Medicine
  • Eating, Nutrition, and Metabolism
  • Microbiome
  • and 7 more
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research